133 related articles for article (PubMed ID: 38849640)
1. Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury.
Garcia B; Ter Schiphorst B; Santos K; Su F; Dewachter L; Vasques-Nóvoa F; Rocha-Oliveira E; Roncon-Albuquerque R; Uba T; Hartmann O; Picod A; Azibani F; Callebert J; Goldman S; Annoni F; Favory R; Vincent JL; Creteur J; Taccone FS; Mebazaa A; Herpain A
Intensive Care Med Exp; 2024 Jun; 12(1):53. PubMed ID: 38849640
[TBL] [Abstract][Full Text] [Related]
2. Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock.
Garcia B; Su F; Dewachter L; Favory R; Khaldi A; Moiroux-Sahraoui A; Annoni F; Vasques-Nóvoa F; Rocha-Oliveira E; Roncon-Albuquerque R; Hubesch G; Njimi H; Vincent JL; Taccone FS; Creteur J; Herpain A
Crit Care; 2022 Sep; 26(1):281. PubMed ID: 36117167
[TBL] [Abstract][Full Text] [Related]
3. Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics.
Deniau B; Rehfeld L; Santos K; Dienelt A; Azibani F; Sadoune M; Kounde PR; Samuel JL; Tolpannen H; Lassus J; Harjola VP; Vodovar N; Bergmann A; Hartmann O; Mebazaa A; Blet A
Eur J Heart Fail; 2020 Feb; 22(2):290-299. PubMed ID: 31472040
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: A proof of concept study.
Deniau B; Blet A; Santos K; Vaittinada Ayar P; Genest M; Kästorf M; Sadoune M; de Sousa Jorge A; Samuel JL; Vodovar N; Bergmann A; Mebazaa A; Azibani F
PLoS One; 2020; 15(8):e0238039. PubMed ID: 32853284
[TBL] [Abstract][Full Text] [Related]
5. The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.
Teixeira JP; Perez Ingles D; Barton JB; Dean JT; Garcia P; Kunkel SJ; Sarangarm P; Weiss NK; Schaich CL; Busse LW; Nielsen ND
Trials; 2024 Mar; 25(1):182. PubMed ID: 38475822
[TBL] [Abstract][Full Text] [Related]
6. Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study.
Blet A; Deniau B; Santos K; van Lier DPT; Azibani F; Wittebole X; Chousterman BG; Gayat E; Hartmann O; Struck J; Bergmann A; Antonelli M; Beishuizen A; Constantin JM; Damoisel C; Deye N; Di Somma S; Dugernier T; François B; Gaudry S; Huberlant V; Lascarrou JB; Marx G; Mercier E; Oueslati H; Pickkers P; Sonneville R; Legrand M; Laterre PF; Mebazaa A;
Crit Care; 2021 Feb; 25(1):61. PubMed ID: 33588925
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin 1-7 in an experimental septic shock model.
Garcia B; Su F; Manicone F; Dewachter L; Favory R; Khaldi A; Moiroux-Sahroui A; Moreau A; Herpain A; Vincent JL; Creteur J; Taccone FS; Annoni F
Crit Care; 2023 Mar; 27(1):106. PubMed ID: 36915144
[TBL] [Abstract][Full Text] [Related]
8. Circulating Dipeptidyl Peptidase 3 Modulates Systemic and Renal Hemodynamics Through Cleavage of Angiotensin Peptides.
Picod A; Placier S; Genest M; Callebert J; Julian N; Zalc M; Assad N; Nordin H; Santos K; Gaudry S; Chatziantoniou C; Mebazaa A; Azibani F
Hypertension; 2024 Apr; 81(4):927-935. PubMed ID: 38334001
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis.
Corrêa TD; Jeger V; Pereira AJ; Takala J; Djafarzadeh S; Jakob SM
Crit Care Med; 2014 Aug; 42(8):e550-9. PubMed ID: 24797374
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl Amino-Peptidase 3 (DPP3) as an Early Marker of Severity in a Patient Population with Cardiogenic Shock.
Innelli P; Lopizzo T; Paternò G; Bruno N; Radice RP; Bertini P; Marabotti A; Luzi G; Stabile E; Di Fazio A; Pittella G; Paternoster G
Diagnostics (Basel); 2023 Apr; 13(7):. PubMed ID: 37046568
[TBL] [Abstract][Full Text] [Related]
11. Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial.
Takagi K; Blet A; Levy B; Deniau B; Azibani F; Feliot E; Bergmann A; Santos K; Hartmann O; Gayat E; Mebazaa A; Kimmoun A
Eur J Heart Fail; 2020 Feb; 22(2):279-286. PubMed ID: 31472039
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of extracellular histones by sodium-Β-O-methyl cellobioside sulfate in septic shock.
Garcia B; Su F; Dewachter L; Wang Y; Li N; Remmelink M; Eycken MV; Khaldi A; Favory R; Herpain A; Moreau A; Moiroux-Sahraoui A; Manicone F; Annoni F; Shi L; Vincent JL; Creteur J; Taccone FS
Crit Care; 2023 Nov; 27(1):458. PubMed ID: 38001494
[TBL] [Abstract][Full Text] [Related]
13. [Adequate fluid resuscitation in septic shock with high catecholamine doses].
Lewejohann JC; Braasch H; Hansen M; Zimmermann C; Muhl E; Keck T
Med Klin Intensivmed Notfmed; 2016 Sep; 111(6):514-24. PubMed ID: 26555619
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure.
Boorsma EM; Ter Maaten JM; Damman K; van Veldhuisen DJ; Dickstein K; Anker SD; Filippatos G; Lang CC; Metra M; Santos K; Voors AA
Eur J Heart Fail; 2021 Jun; 23(6):947-953. PubMed ID: 33742751
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the renin-angiotensin system in septic shock: Mechanistic insights and application of angiotensin II in clinical management.
Senatore F; Balakumar P; Jagadeesh G
Pharmacol Res; 2021 Dec; 174():105916. PubMed ID: 34597810
[TBL] [Abstract][Full Text] [Related]
16. Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock:
van Lier D; Picod A; Marx G; Laterre PF; Hartmann O; Knothe C; Azibani F; Struck J; Santos K; Zimmerman J; Bergmann A; Mebazaa A; Pickkers P
Front Med (Lausanne); 2022; 9():1058235. PubMed ID: 36530868
[TBL] [Abstract][Full Text] [Related]
17. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.
Dellinger RP; Levy MM; Rhodes A; Annane D; Gerlach H; Opal SM; Sevransky JE; Sprung CL; Douglas IS; Jaeschke R; Osborn TM; Nunnally ME; Townsend SR; Reinhart K; Kleinpell RM; Angus DC; Deutschman CS; Machado FR; Rubenfeld GD; Webb SA; Beale RJ; Vincent JL; Moreno R;
Crit Care Med; 2013 Feb; 41(2):580-637. PubMed ID: 23353941
[TBL] [Abstract][Full Text] [Related]
18. ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock.
Leisman DE; Handisides DR; Busse LW; Chappell MC; Chawla LS; Filbin MR; Goldberg MB; Ham KR; Khanna AK; Ostermann M; McCurdy MT; Adams CD; Hodges TN; Bellomo R;
Crit Care; 2024 Apr; 28(1):130. PubMed ID: 38637829
[TBL] [Abstract][Full Text] [Related]
19. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.
Dellinger RP; Levy MM; Rhodes A; Annane D; Gerlach H; Opal SM; Sevransky JE; Sprung CL; Douglas IS; Jaeschke R; Osborn TM; Nunnally ME; Townsend SR; Reinhart K; Kleinpell RM; Angus DC; Deutschman CS; Machado FR; Rubenfeld GD; Webb S; Beale RJ; Vincent JL; Moreno R;
Intensive Care Med; 2013 Feb; 39(2):165-228. PubMed ID: 23361625
[TBL] [Abstract][Full Text] [Related]
20. FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.
Senatore F; Jagadeesh G; Rose M; Pillai VC; Hariharan S; Liu Q; McDowell TY; Sapru MK; Southworth MR; Stockbridge N
Am J Cardiovasc Drugs; 2019 Feb; 19(1):11-20. PubMed ID: 30144016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
